Outlook Therapeutics OTLK
$ 2.28
10.68%
Annual report 2024
added 12-27-2024
Country |
USA |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Lawrence Kenyon |
Employees in the company |
14 |
Shares |
18.5 M |
Market Cap[1] |
$ 42.3 M |
EBITDA (LTM) |
$ -91.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.